When they do the Tox studies they have to use what they have produced in the engineering run which is designed to be used for human clinical trials...
They cant use what they originally done even though they had some fermentation in that test because that process was not up to scratch to go to trials with...
They have to use what they are going to trials with for the Tox study..
- Forums
- ASX - By Stock
- PAB
- Ann: Stable Cell Line for Production of PAT-DX3 Established
Ann: Stable Cell Line for Production of PAT-DX3 Established, page-37
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 5181591 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 2176958 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 5181591 | 0.006 |
18 | 8630976 | 0.005 |
7 | 4425000 | 0.004 |
6 | 2930016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 2176958 | 5 |
0.008 | 2057547 | 3 |
0.009 | 133332 | 1 |
0.010 | 1592000 | 4 |
0.011 | 1080000 | 2 |
Last trade - 11.05am 16/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online